Amarin Corp Plc (AMRN)

[HDGabor]

Yes, the number is not exact number, it is just a indicative, “best estimate” (including the total). Using a statistical methodology, projected based on sample (that is cover 66% of the universe). It is not reflect accurate number, but shows the trend, the app. breakdown of total into NRx and Refill.

The "issue" that while other drugs have near to 2.0 NRx:Refill ratio (ie.: Lovaza has avg. 1.8), Vascepa - within the same statistical model - has only 1.2.

a.) If Vascepa has the same ratio as other drugs it could generate 25% higher Gross Margin.
b.) the ratio suggest that 40% of patients do not take Vascepa after the first script and it is not good